ORTX - Orchard Therapeutics plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5466
Avg. Estimate-0.43-0.45-1.57-1.75
Low Estimate-0.46-0.49-1.76-2.09
High Estimate-0.38-0.41-0.79-0.85
Year Ago EPSN/A-0.35-10.22-1.57
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3456
Avg. Estimate670k360k2.48M1.43M
Low EstimateN/AN/A1.9MN/A
High Estimate1.5M1M3.4M2.73M
Year Ago SalesN/A500k2.08M2.48M
Sales Growth (year/est)N/A-28.00%19.50%-42.30%
Earnings HistoryInvalid Date3/30/20196/29/20199/29/2019
EPS Est.N/A-0.94-0.36-0.43
EPS ActualN/A-0.35-0.56-0.38
DifferenceN/A0.59-0.20.05
Surprise %N/A62.80%-55.60%11.60%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.43-0.45-1.57-1.75
7 Days Ago-0.43-0.49-1.57-1.89
30 Days Ago-0.46-0.48-1.66-1.85
60 Days Ago-0.46-0.48-1.66-1.85
90 Days Ago-0.48-0.55-1.58-1.72
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A1N/A
Up Last 30 Days1111
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A1N/A
Growth EstimatesORTXIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.02
Next Qtr.-28.60%N/AN/A0.06
Current Year84.60%N/AN/A-0.03
Next Year-11.50%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A